Abstract:Background: Sepsis is a life-threatening organ dysfunction condition produced by dysregulation of the host response to infection. It is now characterized by a high clinical morbidity and mortality rate, endangering patients' lives and health. The purpose of this study was to determine the value of Long chain non-coding RNA (LncRNA) RP3_508I15.21, RP11_295G20.2, and LDLRAD4_AS1 in the diagnosis of adult sepsis patients and to develop a Nomogram prediction model. Methods: We screened adult sepsis microarray datasets GSE57065 and GSE95233 from the GEO database and performed differentially expressed genes (DEGs), weighted gene co-expression network analysis (WGCNA), and machine learning methods to find the genes by random forest (Random Forest), least absolute shrinkage and selection operator (LASSO), and support vector machine (SVM), respectively, with GSE95233 as the training set and GSE57065 as the validation set. Differentially expressed genes (DEGs), weighted gene co-expression network analysis (WGCNA), boxplot statistical analysis, and ROC analysis by Random Forest, Least Absolute Shrinkage and Selection Operator (LASSO), and Support Vector Machine (SVM) machine learning methods were used to identify characteristic genes and build the Nomogram Prediction model. Results: GSE95233 yielded a total of 1069 genes, 102 of which were sepsis-related and 22 of which were non-sepsis controls. GSE57065 yielded a total of 899 genes, with 467 up-regulated and 432 down-regulated, including 82 sepsis-related genes and 25 non-sepsis control genes. WGCNA analysis excluded outlier samples, leaving 2,029 genes for relationship analysis between sepsis- and non-sepsis patient-associated LncRNA network representation modules, as well as Wein plots of differential genes versus genes in key modules of weighted co-expression network analysis to analyze gene intersections. Machine Learning found the sepsis-related characteristic LncRNAs RP3-508I15.21, RP11-295G20.2, LDLRAD4-AS1, and CTD-2542L18.1. The datasets GSE95233 and GSE57065 were analyzed using Boxplot against the screened genes listed above, respectively. The p-value between the sepsis and non-sepsis groups was less than 0.05, indicating that anomalies were statistically significant. CTD-2542L18.1 in dataset GSE57065 had an AUC value of 0.638, which was less than 0.7 and did not indicate diagnostic significance, but RP3-508I15.21, RP11-295G20.2, and LDLRAD4-AS1 had AUC values more than 0.7 after ROC analysis. All four sepsis-associated LncRNA ROC analyses in dataset GSE95233 exhibited AUC values more than 0.7, indicating diagnostic significance. Conclusion: LncRNAs RP3_508I15.21, RP11_295G20.2, and LDLRAD4_AS1 have some utility in the diagnosis and treatment of adult sepsis patients, as well as some reference importance in guiding the diagnosis and treatment of clinical sepsis.

Identification of potential biomarkers and pathways for sepsis using RNA sequencing technology and bioinformatic analysis

Insights into the Molecular Mechanisms in Sepsis with Microarray Technology.

Identification of Potential Biomarkers and Immune Features of Sepsis Using Bioinformatics Analysis

Identifying Six Chromatin Remodeling-related Genes As Diagnostic Biomarkers in Sepsis Using Bioinformatic Analyses

Identification of hub genes for adult patients with sepsis via RNA sequencing

Author Correction: Identification of Hub Genes for Adult Patients with Sepsis Via RNA Sequencing

Identification of potential biomarkers for sepsis based on neutrophil extracellular trap-related genes

The significance of long chain non-coding RNA signature genes in the diagnosis and management of sepsis patients, and the development of a prediction model

Identification of Potential Diagnostic and Prognostic Biomarkers for Sepsis Based on Machine Learning

Identification of key genes as potential diagnostic biomarkers in sepsis by bioinformatics analysis

Identification of the Diagnostic Signature of Sepsis Based on Bioinformatic Analysis of Gene Expression and Machine Learning

Integrative analysis of metabolomics and transcriptomics to uncover biomarkers in sepsis

Exploring the biomarkers and potential therapeutic drugs for sepsis via integrated bioinformatic analysis

Bioinformatics Analysis for Identifying Pertinent Pathways and Genes in Sepsis

Identification of Potential Early Diagnostic Biomarkers of Sepsis

Single-cell RNA sequencing and transcriptomic analysis reveal key genes and regulatory mechanisms in sepsis

Analysis of ceRNA Network and Identification of Potential Treatment Target and Biomarkers of Endothelial Cell Injury in Sepsis

Identification and validation of key biomarkers based on RNA methylation genes in sepsis

Novel Biomarkers Associated with Sepsis

Identification of key biomarkers and therapeutic targets in sepsis through coagulation-related gene expression and immune pathway analysis

Identification of hub genes for adult patients with sepsis via construction of a microRNA-mRNA-PPI network